Tag: Therapeutics
Pretzel Therapeutics Receives Investment from Mito Fund
Pretzel Therapeutics, a Boston, MA-based firm biotechnology firm creating therapies for POLG and mtDNA depletion associated mitochondrial illnesses, acquired…
Paradigm Therapeutics Receives Additional Investment From Eshelman Ventures
Paradigm Therapeutics, a Mount Nice, SC-based biopharmaceutical firm, acquired an extra funding of $12.6M from Eshelman Ventures. It introduced…
Vima Therapeutics Raises $60M in Series A Funding
Vima Therapeutics, a Cambridge, MA-based clinical-stage biotechnology firm, raised $60M in Sequence A funding. The spherical was led…
Grin Therapeutics Closes $140M Series D Financing
Grin Therapeutics, Inc., a NYC-based chief within the improvement of therapies to deal with critical neurodevelopmental issues, closed…
Remedy Plan Therapeutics Raises $18M Financing
Remedy Plan Therapeutics, a Gaithersburg, MD-based clinical-stage pharmaceutical firm creating new, hyperbolic NAMPT inhibitors, raised $18M in funding.…
Sirius Therapeutics Raises Nearly $50M in Series B2 Funding
Sirius Therapeutics, a San Diego, CA-based developer of siRNA therapeutics for sufferers with power illnesses, raised practically $50M…
Feldan Therapeutics Receives Investment from Zynext Ventures
Feldan Therapeutics, a Québec Metropolis, Québec, Canada-based early clinical-stage pharmaceutical firm, obtained an funding from Zynext Ventures. The quantity…
Atsena Therapeutics Raises $150M in Series C Financing
Atsena Therapeutics, a Durham, NC-based clinical-stage gene remedy firm, raised $150M in Collection C funding. The spherical was…
Augustine Therapeutics Raises EUR 77.7M in Series A Funding
Augustine Therapeutics, a Leuven, Belgium-based biotechnology firm centered on creating new therapies by means of the inhibition of…
Montara Therapeutics Closes $20M Seed Expansion
Montara Therapeutics, a San Francisco, CA-based biotech firm empowering brain-selective therapies for CNS illnesses, raised $20M in Seed…
Illexcor Therapeutics Receives Investment From Zynext Ventures
Illexcor Therapeutics, a Richmond, VA-based biopharmaceutical firm growing new oral therapies for sickle cell illness (SCD), acquired an…
Mair Therapeutics Raises Pre-Seed Funding
Mair Therapeutics, a Nijmegen, the Netherlands-based biotechnology startup growing remedies for neurodegenerative problems, raised an undisclosed quantity in…